Cumberland Pharmaceuticals CPIX Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's operating income?
- Cumberland Pharmaceuticals (CPIX) reported operating income of -$3.13M in Q1 2026.
- How has Cumberland Pharmaceuticals's operating income changed year-over-year?
- Cumberland Pharmaceuticals's operating income decreased by 342.2% year-over-year, from $1.29M to -$3.13M.
- What is the long-term trend for Cumberland Pharmaceuticals's operating income?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's operating income has grown at a -22.3% compound annual growth rate (CAGR), from -$7.68M to -$2.79M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.